Rocket Pharmaceuticals Inc (RCKT) COM USD0.01

Sell:$2.35Buy:$2.40$3.93 (62.68%)

NASDAQ:2.47%
Market closed | Prices delayed by at least 15 minutes
Sell:$2.35
Buy:$2.40
Change:$3.93 (62.68%)
Market closed | Prices delayed by at least 15 minutes
Sell:$2.35
Buy:$2.40
Change:$3.93 (62.68%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 May 2025
Gaurav ShahCEO
Sell
Tax related
2,253$6.45$14,522.84786,806
20 May 2025
Kinnari PatelPresident/COO
Sell
Tax related
767$6.45$4,944.08441,927
20 May 2025
Jonathan David SchwartzOther Level A
Sell
Tax related
801$6.45$5,163.25235,255
20 May 2025
Martin L WilsonGeneral Counsel
Sell
Tax related
587$6.45$3,783.80149,163
20 May 2025
John MilitelloManager/Officer
Sell
Tax related
357$6.45$2,301.2264,027
16 May 2025
Gaurav ShahCEO
Sell
Tax related
3,621$6.53$23,637.89789,059
16 May 2025
Kinnari PatelPresident/COO
Sell
Tax related
1,409$6.53$9,197.95442,694
16 May 2025
Jonathan David SchwartzOther Level A
Sell
Tax related
1,582$6.53$10,327.30236,056
16 May 2025
Martin L WilsonGeneral Counsel
Sell
Tax related
946$6.53$6,175.49149,750
16 May 2025
John MilitelloManager/Officer
Sell
Tax related
655$6.53$4,275.8464,384

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
12 December 2024
RTW INVESTMENTS LPHedge Fund
Buy
Regular purchase transaction
400,000$12.49$4,996,000.003,526,955
16 August 2024
Gaurav ShahCEO
Sell
Tax related
9,650$18.50$178,563.60718,419
21 February 2025
Gaurav ShahCEO
Sell
Tax related
16,303$10.58$172,485.74772,680
21 November 2024
Gaurav ShahCEO
Sell
Tax related
11,091$13.05$144,781.91707,328
10 April 2025
Gaurav ShahCEO
Buy
Regular purchase transaction
20,000$5.08$101,600.00792,680

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.